Emergent BioSolutionsRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Fuad El-Hibri founds BioPort (5 Sep 1998) and acquires Michigan's anthrax-vaccine plant. Renamed Emergent BioSolutions in 2004. BioThrax is the franchise.
Emergent IPOs on the NYSE as EBS. The buyer is the US government (DoD and SNS), not ACIP retail.
FDA and HHS halt J&J COVID production at Emergent's Baltimore Bayview plant after contamination findings (Apr 2021). The CDMO expansion thesis breaks. Distressed operator after this.
FDA approves CYFENDUS (anthrax vaccine adsorbed, adjuvanted) on 20 Jul 2023 as a two-dose post-exposure product. Complements BioThrax for BARDA/SNS.